Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 728605, 6 pages
http://dx.doi.org/10.1155/2012/728605
Review Article

Role of Hsp90 in Systemic Lupus Erythematosus and Its Clinical Relevance

1Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA
2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Received 14 July 2012; Accepted 6 September 2012

Academic Editor: Kamal D. Moudgil

Copyright © 2012 Hem D. Shukla and Paula M. Pitha. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lindquist, “The heat-shock response,” Annual Review of Biochemistry, vol. 55, pp. 1151–1191, 1986. View at Google Scholar
  2. L. E. Hightower and L. M. Hendershot, “Molecular chaperones and the heat shock response at Cold Spring Harbor,” Cell Stress Chaperones, vol. 2, pp. 1–11, 1997. View at Google Scholar
  3. A. L. Fink, “Chaperone-mediated protein folding,” Physiological Reviews, vol. 79, no. 2, pp. 425–449, 1999. View at Google Scholar · View at Scopus
  4. F. U. Hartl and M. Hayer-Hartl, “Protein folding. Molecular chaperones in the cytosol: from nascent chain to folded protein,” Science, vol. 295, no. 5561, pp. 1852–1858, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. I. Morimoto, “Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators,” Genes and Development, vol. 12, no. 24, pp. 3788–3796, 1998. View at Google Scholar · View at Scopus
  6. A. G. Pockley, “Heat shock proteins as regulators of the immune response,” The Lancet, vol. 362, no. 9382, pp. 469–476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Srivastava, “Roles of heat-shock proteins in innate and adaptive immunity,” Nature Reviews Immunology, vol. 2, no. 3, pp. 185–194, 2002. View at Google Scholar · View at Scopus
  8. D. F. Liao, Z. G. Jin, A. S. Baas et al., “Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 275, no. 1, pp. 189–196, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Barreto, J. M. Gonzalez, E. Kabingu, A. Asea, and S. Fiorentino, “Stress-induced release of HSC70 from human tumors,” Cellular Immunology, vol. 222, no. 2, pp. 97–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. G. Pockley, J. Bulmer, B. M. Hanks, and B. H. Wright, “Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals,” Cell Stress and Chaperones, vol. 4, no. 1, pp. 29–35, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Njemini, I. Bautmans, O. O. Onyema, K. Van Puyvelde, C. Demanet, and T. Mets, “Circulating heat shock protein 70 in health, aging and disease,” BMC Immunology, vol. 12, article 24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. J. M. Ripley, D. A. Isenberg, and D. S. Latchman, “Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90,” Journal of Autoimmunity, vol. 17, no. 4, pp. 341–346, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Sreedhar, É. Kalmár, P. Csermely, and Y. F. Shen, “Hsp90 isoforms: functions, expression and clinical importance,” FEBS Letters, vol. 562, no. 1–3, pp. 11–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Grammatikakis, A. Vultur, C. V. Ramana et al., “The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation,” Journal of Biological Chemistry, vol. 277, no. 10, pp. 8312–8320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Dutta and M. Inouye, “GHKL, an emergent ATPase/kinase superfamily,” Trends in Biochemical Sciences, vol. 25, no. 1, pp. 24–28, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Csermely, T. Schnaider, C. Soti, Z. Prohászka, and G. Nardai, “The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review,” Pharmacology and Therapeutics, vol. 79, no. 2, pp. 129–168, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Åkerfelt, R. I. Morimoto, and L. Sistonen, “Heat shock factors: integrators of cell stress, development and lifespan,” Nature Reviews Molecular Cell Biology, vol. 11, no. 8, pp. 545–555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Stephanou and D. S. Latchman, “Transcriptional modulation of heat-shock protein gene expression,” Biochemistry Research International, vol. 2011, Article ID 238601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. C. Wilkerson, H. S. Skaggs, and K. D. Sarge, “HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression,” Cell Stress and Chaperones, vol. 12, no. 3, pp. 283–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. U. Zügel and S. H. E. Kaufmann, “Immune response against heat shock proteins in infectious diseases,” Immunobiology, vol. 201, no. 1, pp. 22–35, 1999. View at Google Scholar · View at Scopus
  21. S. Tasneem, N. Islam, and R. Ali, “Crossreactivity of SLE autoantibodies with 70 kDa heat shock proteins of Mycobacterium tuberculosis,” Microbiology and Immunology, vol. 45, no. 12, pp. 841–846, 2001. View at Google Scholar · View at Scopus
  22. E. S. Pires, A. K. Choudhury, S. Idicula-Thomas, and V. V. Khole, “Anti-HSP90 autoantibodies in sera of infertile women identify a dominant, conserved epitope EP6 (380–389) of HSP90 beta protein,” Reproductive Biology and Endocrinology, vol. 9, article 16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Tsan and B. Gao, “Heat shock protein and innate immunity,” Cellular & Molecular Immunology, vol. 1, no. 4, pp. 274–279, 2004. View at Google Scholar · View at Scopus
  24. Y. Tamura, P. Peng, K. Liu, M. Daou, and P. K. Srivastava, “Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations,” Science, vol. 278, no. 5335, pp. 117–120, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Murshid, J. Gong, and S. K. Calderwood, “Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation,” Expert Review of Vaccines, vol. 7, no. 7, pp. 1019–1030, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Panchapakesan, M. Daglis, and P. Gatenby, “Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus,” Immunology and Cell Biology, vol. 70, no. 5, pp. 295–300, 1992. View at Google Scholar · View at Scopus
  27. T. R. J. Stevens, S. F. Smith, and D. S. Rampton, “Antibodies to human recombinant lipocortin-I in inflammatory bowel disease,” Clinical Science, vol. 84, no. 4, pp. 381–386, 1993. View at Google Scholar · View at Scopus
  28. C. Georgopoulos and H. McFarland, “Heat shock proteins in multiple sclerosis and other autoimmune diseases,” Immunology Today, vol. 14, no. 8, pp. 373–375, 1993. View at Google Scholar · View at Scopus
  29. F. Hauet-Broere, L. Wieten, T. Guichelaar, S. Berlo, R. van der Zee, and W. Van Eden, “Heat shock proteins induce T cell regulation of chronic inflammation,” Annals of the Rheumatic Diseases, vol. 65, no. 3, pp. iii65–iii68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Van Eden, G. Wick, S. Albani, and I. Cohen, “Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases,” Annals of the New York Academy of Sciences, vol. 1113, pp. 217–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Multhoff, “Heat shock proteins in immunity,” Handbook of Experimental Pharmacology, no. 172, pp. 279–304, 2006. View at Google Scholar · View at Scopus
  32. S. I. Yokota and N. Fujii, “Immunomodulatory activity of extracellular heat shock proteins and their autoantibodies,” Microbiology and Immunology, vol. 54, no. 5, pp. 299–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Hoseki, R. Ushioda, and K. Nagata, “Mechanism and components of endoplasmic reticulum-associated degradation,” Journal of Biochemistry, vol. 147, no. 1, pp. 19–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Araki and K. Nagata, “Protein folding and quality control in the ER,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 11, Article ID a007526, 2011. View at Publisher · View at Google Scholar
  35. K. Mori, “Tripartite management of unfolded proteins in the endoplasmic reticulum,” Cell, vol. 101, no. 5, pp. 451–454, 2000. View at Google Scholar · View at Scopus
  36. P. Walter and D. Ron, “The unfolded protein response: from stress pathway to homeostatic regulation,” Science, vol. 334, pp. 1081–1086, 2011. View at Google Scholar
  37. H. Yoshida, “ER stress and diseases,” FEBS Journal, vol. 274, no. 3, pp. 630–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Mahler, R. Raijmakers, and M. J. Fritzler, “Challenges and controversies in autoantibodies associated with systemic rheumatic diseases,” Current Rheumatology Reviews, vol. 3, no. 1, pp. 67–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. K. Shimp, C. B. Chafin, N. L. Regna et al., “Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus,” Cellular & Molecular Immunology, vol. 9, pp. 255–266, 2012. View at Google Scholar
  40. A. Kenderov, V. Minkova, D. Mihailova et al., “Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies,” Clinical and Experimental Immunology, vol. 129, no. 1, pp. 169–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Cervera, M. A. Khamashta, J. Font et al., “Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients,” Medicine, vol. 82, no. 5, pp. 299–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Sekine, H. Watanabe, and G. S. Gilkeson, “Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Faslpr mice,” Journal of Immunology, vol. 172, no. 6, pp. 3913–3921, 2004. View at Google Scholar · View at Scopus
  43. T. Wu and R. M. Tanguay, “Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?” Cell Stress and Chaperones, vol. 11, no. 1, pp. 1–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Liu, J. Dai, H. Zheng, D. Stoilova, S. Sun, and Z. Li, “Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15824–15829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Fenton, S. Fismen, A. Hedberg et al., “Anti-dsDNA antibodies promote initiation, and acquired loss of renal dnase1 promotes progression of lupus nephritis in autoimmune (NZB×NZW)F1 Mice,” PloS ONE, vol. 4, no. 12, Article ID e8474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Levy, Y. Sherer, A. Ahmed et al., “A study of 20 SLE patients with intravenous immunoglobulin—clinical and serologic response,” Lupus, vol. 8, no. 9, pp. 705–712, 1999. View at Google Scholar · View at Scopus
  47. A. P. Manderson, M. Botto, and M. J. Walport, “The role of complement in the development of systemic lupus erythematosus,” Annual Review of Immunology, vol. 22, pp. 431–456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Agarwal and C. Cunningham-Rundles, “Autoimmunity in common variable immunodeficiency,” Current Allergy and Asthma Reports, vol. 9, no. 5, pp. 347–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. R. Christensen, M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik, “Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus,” Journal of Experimental Medicine, vol. 202, no. 2, pp. 321–331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. J. W. Bauer, E. C. Baechler, M. Petri et al., “Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus,” PLoS Medicine, vol. 3, no. 12, Article ID e491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. Liu and A. Davidson, “Taming lupus-a new understanding of pathogenesis is leading to clinical advances,” Nature Medicine, vol. 18, pp. 871–882, 2012. View at Google Scholar
  52. J. M. Han, N. H. Kwon, J. Y. Lee et al., “Identification of gp96 as a novel target for treatment of autoimmune disease in mice,” PloS ONE, vol. 5, no. 3, Article ID e9792, 2010. View at Google Scholar · View at Scopus
  53. C. Dello Russo, P. E. Polak, P. R. Mercado et al., “The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis,” Journal of Neurochemistry, vol. 99, no. 5, pp. 1351–1362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. J. W. Rice, J. M. Veal, R. P. Fadden et al., “Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 58, no. 12, pp. 3765–3775, 2008. View at Publisher · View at Google Scholar · View at Scopus